These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1475063)

  • 1. Calcium, magnesium and aluminum concentrations in Parkinson's disease.
    Yasui M; Kihira T; Ota K
    Neurotoxicology; 1992; 13(3):593-600. PubMed ID: 1475063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aluminum deposition in the central nervous system tissues of patients with Parkinson's disease].
    Yasui M; Kihira T; Ota K; Mukoyama M; Adachi K
    Rinsho Shinkeigaku; 1991 Oct; 31(10):1095-8. PubMed ID: 1802464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcium-deficient diets on manganese deposition in the central nervous system and bones of rats.
    Yasui M; Ota K; Garruto RM
    Neurotoxicology; 1995; 16(3):511-7. PubMed ID: 8584282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease.
    Bissette G; Nemeroff CB; Decker MW; Kizer JS; Agid Y; Javoy-Agid F
    Ann Neurol; 1985 Apr; 17(4):324-8. PubMed ID: 4004152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of magnesium, calcium and aluminum metabolism in rats and monkeys maintained on calcium-deficient diets.
    Yasui M; Yase Y; Ota K; Garruto RM
    Neurotoxicology; 1991; 12(3):603-14. PubMed ID: 1745443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Similarities in calcium and magnesium metabolism between amyotrophic lateral sclerosis and calcification of the spinal cord in the Kii Peninsula ALS focus].
    Yasui M; Yoshida M; Tamaki T; Taniguchi Y; Ota K
    No To Shinkei; 1997 Aug; 49(8):745-51. PubMed ID: 9282369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum deposition in the central nervous system of patients with amyotrophic lateral sclerosis from the Kii Peninsula of Japan.
    Yasui M; Yase Y; Ota K; Garruto RM
    Neurotoxicology; 1991; 12(3):615-20. PubMed ID: 1745444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
    Zhang J; Zhang Y; Wang J; Cai P; Luo C; Qian Z; Dai Y; Feng H
    Brain Res; 2010 May; 1330():124-30. PubMed ID: 20303339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of magnesium, calcium and aluminum deposition in bone in situ].
    Yasui M; Yase Y; Ota K
    No To Shinkei; 1991 Jun; 43(6):577-82. PubMed ID: 1910940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of zinc and iron in the brains of Guamanian patients with amyotrophic lateral sclerosis and parkinsonism-dementia.
    Yasui M; Ota K; Garruto RM
    Neurotoxicology; 1993; 14(4):445-50. PubMed ID: 8164889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.
    O'Neill J; Schuff N; Marks WJ; Feiwell R; Aminoff MJ; Weiner MW
    Mov Disord; 2002 Sep; 17(5):917-27. PubMed ID: 12360540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum-containing antacids as a cause of idiopathic Parkinson's disease.
    Altschuler E
    Med Hypotheses; 1999 Jul; 53(1):22-3. PubMed ID: 10499820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution of calcium and magnesium in soft tissues, especially in the central nervous system, and bone of rats fed with low calcium-magnesium with or without aluminum loading diets].
    Yasui M; Yano I; Yase Y; Ota K
    No To Shinkei; 1990 Mar; 42(3):283-9. PubMed ID: 2369533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY; Li YX; Zee CS
    Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease.
    Schocke MF; Seppi K; Esterhammer R; Kremser C; Mair KJ; Czermak BV; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2004 Apr; 21(4):1443-51. PubMed ID: 15050569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.